Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Greg Allen, Founder and CEO of Decision ...
Kęstutis Budrys, Lithuanian Foreign Mini...
Rep. Byron Donalds, R-Fla., discusses Pr...
President Donald Trump said he would ban...
Gavin Newsom faces criticism over Califo...
Matrix Asset CIO David Katz shares inves...
In 2012, Cousins Maine Lobster co-founde...
CBC Leadership says nearly all of its 62...
Just two months after it emerged from st...
AI leaders are suddenly talking about "p...
Max Levchin, Affirm CEO, joins 'Closing ...
CNBC Business News Update with Jessica E...
CFP Ben Henry-Moreland breaks down what ...